Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Cancer immunology and colorectal cancer recurrence

L. Vannucci,

. 2011 ; 3 () : 1421-31. [pub] 20110601

Language English Country United States

Document type Journal Article, Research Support, Non-U.S. Gov't, Review

Persistent link   https://www.medvik.cz/link/bmc12027513

The recurrence of a cancer - local or distant (metastasis) - is manifested by the persistence of cancer cells in the organism after the ablation of the primary lesion, an ineffective anticancer immune response, and by the activity of biological/immunological factors that can stimulate and sustain its development. This review focuses on colorectal carcinoma and discusses some aspects of cancer immunology regarding cancer development and its recurrence. It is addressed also to the clinician to provide new insights helpful for designing better therapeutic strategies and patient's follow up. Therapeutic approaches used during and after surgical treatments, found capable of modulating immunity (differently affecting disease outcome), will also be described.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12027513
003      
CZ-PrNML
005      
20230331103402.0
007      
ta
008      
120817e20110601xxu f 000 0#eng||
009      
AR
024    7_
$a 10.2741/233 $2 doi
035    __
$a (PubMed)21622278
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Vannucci, Luca $u Laboratory of Natural Cell Immunity, Department of Immunology and Gnotobiology, Institute of Microbiology, Academy of Sciences of the Czech Republic, vvi, Prague, Czech Republic. vannucci@biomed.cas.cz
245    10
$a Cancer immunology and colorectal cancer recurrence / $c L. Vannucci,
520    9_
$a The recurrence of a cancer - local or distant (metastasis) - is manifested by the persistence of cancer cells in the organism after the ablation of the primary lesion, an ineffective anticancer immune response, and by the activity of biological/immunological factors that can stimulate and sustain its development. This review focuses on colorectal carcinoma and discusses some aspects of cancer immunology regarding cancer development and its recurrence. It is addressed also to the clinician to provide new insights helpful for designing better therapeutic strategies and patient's follow up. Therapeutic approaches used during and after surgical treatments, found capable of modulating immunity (differently affecting disease outcome), will also be described.
650    _2
$a kolorektální nádory $x imunologie $x patofyziologie $x terapie $7 D015179
650    _2
$a lidé $7 D006801
650    _2
$a imunoterapie $x metody $7 D007167
650    _2
$a zánět $x imunologie $7 D007249
650    _2
$a NF-kappa B $x metabolismus $7 D016328
650    _2
$a metastázy nádorů $x imunologie $x prevence a kontrola $7 D009362
650    _2
$a lokální recidiva nádoru $x imunologie $x prevence a kontrola $7 D009364
650    _2
$a transkripční faktor STAT3 $x metabolismus $7 D050796
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
773    0_
$w MED00180225 $t Frontiers in bioscience (Scholar edition) $x 1945-0516 $g Roč. 3 (20110601), s. 1421-31
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21622278 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20230331103357 $b ABA008
999    __
$a ok $b bmc $g 949555 $s 784859
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 3 $d 1421-31 $e 20110601 $i 1945-0516 $m Frontiers in bioscience (scholar edition) $n Front Biosci (Schol Ed) $x MED00180225
LZP    __
$a Pubmed-20120817/11/03

Find record

Citation metrics

Archiving options